Pediatrix Medical Group, Inc. Annual Results: Standalone & Consolidated Reports

Annual Results

Results Snapshot

Figures in Million

Consolidate Annual Results

Dec'25

Dec'24

Dec'23

Dec'22

Dec'21

Dec'20

Dec'19

Net Sales

1,913.85

2,012.92

1,994.64

1,972.02

1,911.19

1,733.95

3,513.54

Other Operating Income

0.00

Total Operating income

1,913.85

2,012.92

1,994.64

1,972.02

1,911.19

1,733.95

3,513.54

Raw Material Cost

1,441.97

1,590.80

1,609.25

1,540.62

1,430.10

1,313.07

2,700.40

Purchase of Finished goods

0.00

(Increase) / Decrease In Stocks

0.00

Employee Cost

1,340.87

1,440.83

1,448.28

1,383.32

1,297.48

1,193.94

2,508.78

Power Cost

0.00

Manufacturing Expenses

35.97

40.74

42.08

39.70

68.72

110.48

119.38

Selling and Distribution Expenses

240.79

238.44

227.54

231.40

263.36

248.95

404.64

Other Expenses

-137.68

-148.16

-149.03

-142.30

-136.62

-130.44

-262.82

Total Expenditure (Excl Depreciation)

1,682.76

1,829.24

1,836.79

1,772.02

1,693.45

1,562.02

3,105.05

Operating Profit (PBDIT) excl Other Income

231.1

183.70000000000002

157.89999999999998

200

217.7

171.9

408.5

Other Income

43.58

-1.58

6.39

5.39

22.84

19.50

13.45

Operating Profit (PBDIT)

296.50

214.32

200.42

241.03

272.73

219.87

500.81

Interest

35.97

40.74

42.08

39.70

68.72

110.48

119.38

Exceptional Items

-22.27

-242.69

-170.53

-84.33

-36.63

-73.80

-1,544.54

Gross Profit (PBDT)

471.88

422.12

385.39

431.40

481.10

420.88

813.14

Depreciation

21.83

32.23

36.17

35.64

32.15

28.44

78.86

Profit Before Tax

216.43

-101.34

-48.36

81.37

135.23

7.15

-1,241.98

Tax

51.04

-2.27

12.05

18.81

27.24

16.73

-91.89

Provisions and contingencies

0.00

Profit After Tax

165.39

-99.07

-60.41

62.57

108.01

-9.58

-1,150.09

Extraordinary Items

0.00

Prior Period Expenses

0.00

Other Adjustments

0.00

Net Profit

165.39

-99.07

-60.41

62.57

108.01

-9.58

-1,150.09

Share in Profit of Associates

0.00

Minority Interest

0.00

-0.00

-0.03

0.00

Other related items

0.00

Consolidated Net Profit

165.39

-99.07

-60.41

62.56

107.99

-9.58

-1,150.09

Equity Capital

0.00

Face Value

0.01

Reserves

865.85

764.94

849.06

891.63

896.49

747.49

1,499.00

Earnings per share (EPS)

1.94

-1.19

-0.73

0.79

1.53

-9.55

-17.94

Diluted Earnings per share

1.94

-1.19

-0.73

0.79

1.53

-9.55

-17.94

Operating Profit Margin (Excl OI)

12.07%

9.13%

7.91%

10.14%

11.39%

9.92%

11.63%

Gross Profit Margin

12.45%

-3.43%

-0.61%

5.93%

8.76%

2.05%

-33.1%

PAT Margin

8.64%

-4.92%

-3.03%

3.17%

5.65%

-0.55%

-32.73%

Public Share Holdings (%)

0.0%

Pledged Promotor Holding (%)

0.0%

Annual Analysis Highlights

Net Sales

YoY Growth in year ended Dec 2025 is -4.92% vs 0.92% in Dec 2024

Consolidate Net Profit

YoY Growth in year ended Dec 2025 is 266.90% vs -64.07% in Dec 2024

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Dec 2025 is 17.14% vs 11.29% in Dec 2024

Interest

YoY Growth in year ended Dec 2025 is -11.55% vs -3.33% in Dec 2024

Operating Profit Margin (Excl OI)

YoY Growth in year ended Dec 2025 has improved from Dec 2024

Compare Annual Results Of Pediatrix Medical Group, Inc. With

Select Peers

Figures in Million

Consolidate Annual Results

Change(USD)

Change(%)

Net Sales

1,913.85

606.88

1,306.97

215.36%

Other Operating Income

0.00

Total Operating income

1,913.85

606.88

1,306.97

215.36%

Raw Material Cost

1,441.97

478.83

963.14

201.14%

Purchase of Finished goods

0.00

(Increase) / Decrease In Stocks

0.00

Employee Cost

1,340.87

0.00

1,340.87

Power Cost

0.00

Manufacturing Expenses

35.97

108.46

-72.49

-66.84%

Selling and Distribution Expenses

240.79

223.00

17.79

7.98%

Other Expenses

-137.68

1.56

-139.24

-8,925.64%

Total Expenditure (Excl Depreciation)

1,682.76

825.86

856.90

103.76%

Operating Profit (PBDIT) excl Other Income

231.09

-218.99

450.08

205.53%

Other Income

43.58

86.75

-43.17

-49.76%

Operating Profit (PBDIT)

296.50

-40.61

337.11

830.12%

Interest

35.97

108.46

-72.49

-66.84%

Exceptional Items

-22.27

-0.67

-21.60

-3,223.88%

Gross Profit (PBDT)

471.88

128.05

343.83

268.51%

Depreciation

21.83

91.63

-69.80

-76.18%

Profit Before Tax

216.43

-241.36

457.79

189.67%

Tax

51.04

-15.71

66.75

424.89%

Provisions and contingencies

0.00

Profit After Tax

165.39

-225.68

391.07

173.29%

Extraordinary Items

0.00

Prior Period Expenses

0.00

Other Adjustments

0.00

Net Profit

165.39

-225.68

391.07

173.29%

Share in Profit of Associates

0.00

Minority Interest

0.00

Other related items

0.00

Consolidated Net Profit

165.39

-225.68

391.07

173.29%

Equity Capital

0.00

Face Value

0.01

0.00

Reserves

865.85

1,267.96

-402.11

-31.71%

Earnings per share (EPS)

1.94

-0.30

2.24

746.67%

Diluted Earnings per share

1.94

-0.30

2.24

746.67%

Operating Profit Margin (Excl OI)

12.07%

-36.08%

0.00

48.15%

Gross Profit Margin

12.45%

-24.67%

0.00

37.12%

PAT Margin

8.64%

-37.19%

0.00

45.83%

Public Share Holdings (%)

0.00

0.00%

Pledged Promotor Holding (%)

0.00

0.00%

Annual - Net Sales

Net Sales 191.38 Million

in Dec 2025

Figures in Million

YoY Growth in year ended Dec 2025 is -4.92% vs 0.92% in Dec 2024

Annual - Consolidate Net Profit

Consolidate Net Profit 16.54 Million

in Dec 2025

Figures in Million

YoY Growth in year ended Dec 2025 is 266.90% vs -64.07% in Dec 2024

Annual - Operating Profit (PBDIT)

Operating Profit (PBDIT) 25.29 Million

in Dec 2025

Figures in Million

YoY Growth in year ended Dec 2025 is 17.14% vs 11.29% in Dec 2024

Annual - Interest

Interest 3.60 Million

in Dec 2025

Figures in Million

YoY Growth in year ended Dec 2025 is -11.55% vs -3.33% in Dec 2024

Annual - Operating Profit Margin (Excl OI)

Operating Profit Margin (Excl OI) 12.07%

in Dec 2025

Figures in %

YoY Growth in year ended Dec 2025 has improved from Dec 2024